Active Supportive Care and Symptom Management Grants
| PI Name | Organization - Company | Title |
FOA |
|---|---|---|---|
| Gray, Robert J | Dana-Farber Cancer Inst | Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Basch, Ethan M. | Univ Of North Carolina Chapel Hill | Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Tighiouart, Mourad | Cedars-Sinai Medical Center | Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Mohile, Supriya G | University Of Rochester | Understanding Treatment Tolerability in Older Patients with Cancer | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Hu, Shuiying | Ohio State University | Prevention of paclitaxel-induced peripheral neuropathy with nilotinib | RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions |
| Laack, Nadia N | Mayo Clinic Rochester | Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy | RFA-CA-19-033: Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors |
| Shen, Chan | Pennsylvania State Univ Hershey Med Ctr | The effects of hydrocodone rescheduling on pain management of older lung cancer patients | RFA-DE-22-011: HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans |
| Melemedjian, Ohannes Kevork | University Of Maryland Baltimore | Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy | RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
| Wang, Jing | New York University School Of Medicine | Optimizing the use of ketamine to reduce chronic postsurgical pain | RFA-NS-20-028: HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
| Cheville, Andrea Lynne | Mayo Clinic Rochester | Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNTā (ASCENT) Clinical Trial | RFA-NS-22-002: HEAL Initiative: Advancing Health Equity in Pain Management |
| Brinkman, Tara M | St. Jude Children'S Research Hospital | Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma | RFA-NS-22-037: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities |
| Im, Eun-Ok | Emory University | Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors | RFA-NS-22-037: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities |
| Levine, Jon David | University Of California, San Francisco | Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress |